申请人:Taisho Pharmaceutical Co., Ltd.
公开号:US06156801A1
公开(公告)日:2000-12-05
A 2-phenoxyaniline derivative represented by the formula: ##STR1## wherein R.sup.1 is a hydrogen atom, an amino group or an NHCOR.sup.3 group, R.sup.2 is a halogen atom, an amino group, a cyano group, a C.sub.1-6 alkyl group, a C.sub.1-3 perfluoroalkyl group, an NHCOR.sup.3 group, a CH.sub.2 OR.sup.4 group, an OCH.sub.2 R.sup.5 group or a COR.sup.6 group, R.sup.3 is a C.sub.1-6 alkyl group, R.sup.4 is a hydrogen atom or a C.sub.1-6 alkyl group, R.sup.5 is a hydrogen atom, a C.sub.1-6 alkyl group, a C.sub.1-5 aminoalkyl group, a C.sub.2-7 alkoxy-carbonyl group or a carbamoyl group, and R.sup.6 is a C.sub.1-6 alkyl group or a C.sub.3-8 cycloalkyl group which is unsubstituted or substituted by a halogen atom, an amino group, a cyano group or a straight or branched C.sub.1-6 alkyl group; or a pharmaceutically acceptable salt thereof.
一种2-苯氧基苯胺衍生物,其化学式为:##STR1## 其中,R.sup.1 是氢原子,氨基或NHCOR.sup.3基团,R.sup.2是卤素原子,氨基,氰基,C.sub.1-6烷基,C.sub.1-3全氟烷基,NHCOR.sup.3基团,CH.sub.2 OR.sup.4基团,OCH.sub.2 R.sup.5基团或COR.sup.6基团,R.sup.3是C.sub.1-6烷基,R.sup.4是氢原子或C.sub.1-6烷基,R.sup.5是氢原子,C.sub.1-6烷基,C.sub.1-5氨基烷基,C.sub.2-7烷氧基羰基基团或氨基甲酰基团,R.sup.6是C.sub.1-6烷基或C.sub.3-8环烷基,其未被卤素原子,氨基,氰基或直链或支链C.sub.1-6烷基取代;或其药学上可接受的盐。